Drug intelligence / Profile preview

BXT-251 + Oxysense

Development stage
Preclinical
Lead developer
BioXyTran
Modality
Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Parenteral
01

Overview

BXT-251 + OxySense is a preclinical-stage combination product developed by BioXyTran for organ preservation and transplantation. BXT-251 is an acellular oxygen carrier (AOC) consisting of a hemoglobin-based glycoprotein co-polymer designed to deliver oxygen to tissues and prolong the viability of donor organs during extracorporeal circulation. It is paired with OxySense, a real-time monitoring technology utilizing the MDX Viewer device to measure NADH levels, which serves as a marker for cellular oxygen consumption and energy metabolism. This combination aims to extend organ preservation times from hours to days and improve transplantation outcomes by ensuring adequate tissue oxygenation and monitoring metabolic status.

Other names
BXT-251 + OxySense
02

Targets

NAD (Nicotinamide adenine dinucleotide)NO2- (Nitrite)CO (Carbon monoxide)

Beyond the preview

Go deeper on BXT-251 + Oxysense.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BXT-251 + Oxysense.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call